Paul W Jones1, Gale Harding2, Ingela Wiklund3, Pamela Berry4, Maggie Tabberer4, Ren Yu2, Nancy K Leidy2. 1. Division of Clinical Science, St. George's University of London, London, England. Electronic address: pjones@sgul.ac.uk. 2. Center for Health Outcomes Research, United Biosource Corporation, Bethesda, MD. 3. Center for Health Outcomes Research, United BioSource Corporation, London, England. 4. Global Health Outcomes, GlaxoSmithKline, London, England.
Abstract
BACKGROUND: The COPD Assessment Test (CAT) is an eight-item questionnaire suitable for routine clinical use that shows reliability and validity in stable and exacerbating COPD. METHODS: Study 1 assessed CAT responsiveness to changes in health status in 67 patients during an exacerbation (days 1-14). Study 2 assessed CAT responsiveness in 64 patients undergoing pulmonary rehabilitation (days 1-42). Correlations between CAT and other outcome measures were examined. RESULTS: In study 1, mean 14-day improvement in CAT score was -1.4 ± 5.3 units (P = .03). In patients judged to be responders (clinician defined) change in score was -2.6 ± 4.4; in nonresponders it was -0.2 ± 5.9. In study 2, the mean improvement in CAT score was -2.2 ± 5.3 (P = .002); the effect size for the change was -0.33. Effect size for changes in the Chronic Respiratory Questionnaire-Self Administered Standardized (CRQ-SAS) form domain scores ranged from -0.02 to 0.34. Change in 6-min walk distance (6MWD) was 41 ± 55 m. CAT and CRQ-SAS domain scores correlated at baseline (r = -0.54 to -0.69, P < .0001) and in terms of change following pulmonary rehabilitation (r = -0.39 to -0.63, P < .01). Correlations were less strong between change in the CAT and St. George Respiratory Questionnaire for COPD in study 1 (r < 0.24) and for 6MWD (r < 0.11) in study 2. CONCLUSIONS: These studies indicate that the CAT is sensitive to changes in health status following exacerbations and is as responsive to pulmonary rehabilitation as more complex COPD health status measures.
BACKGROUND: The COPD Assessment Test (CAT) is an eight-item questionnaire suitable for routine clinical use that shows reliability and validity in stable and exacerbating COPD. METHODS: Study 1 assessed CAT responsiveness to changes in health status in 67 patients during an exacerbation (days 1-14). Study 2 assessed CAT responsiveness in 64 patients undergoing pulmonary rehabilitation (days 1-42). Correlations between CAT and other outcome measures were examined. RESULTS: In study 1, mean 14-day improvement in CAT score was -1.4 ± 5.3 units (P = .03). In patients judged to be responders (clinician defined) change in score was -2.6 ± 4.4; in nonresponders it was -0.2 ± 5.9. In study 2, the mean improvement in CAT score was -2.2 ± 5.3 (P = .002); the effect size for the change was -0.33. Effect size for changes in the Chronic Respiratory Questionnaire-Self Administered Standardized (CRQ-SAS) form domain scores ranged from -0.02 to 0.34. Change in 6-min walk distance (6MWD) was 41 ± 55 m. CAT and CRQ-SAS domain scores correlated at baseline (r = -0.54 to -0.69, P < .0001) and in terms of change following pulmonary rehabilitation (r = -0.39 to -0.63, P < .01). Correlations were less strong between change in the CAT and St. George Respiratory Questionnaire for COPD in study 1 (r < 0.24) and for 6MWD (r < 0.11) in study 2. CONCLUSIONS: These studies indicate that the CAT is sensitive to changes in health status following exacerbations and is as responsive to pulmonary rehabilitation as more complex COPD health status measures.
Authors: A Agusti; J J Soler-Cataluña; J Molina; E Morejon; M Garcia-Losa; M Roset; X Badia Journal: Qual Life Res Date: 2015-04-07 Impact factor: 4.147
Authors: Jae Seung Lee; Joon Beom Seo; Sang Min Lee; Tai Sun Park; Sei Won Lee; Yeon-Mok Oh; Ji-Hyun Lee; Eun-Kyung Kim; Tae-Hyung Kim; Joo Hun Park; Seung Soo Sheen; Seong Yong Lim; Ina Jung; Sang-Do Lee Journal: J Thorac Dis Date: 2015-10 Impact factor: 2.895
Authors: Hana Müllerová; Mark T Dransfield; Byron Thomashow; Paul W Jones; Stephen Rennard; Niklas Karlsson; Malin Fageras; Norbert Metzdorf; Stefano Petruzzelli; Jean Rommes; Frank C Sciurba; Maggie Tabberer; Debora Merrill; Ruth Tal-Singer Journal: Am J Respir Crit Care Med Date: 2020-05-01 Impact factor: 21.405
Authors: MeiLan K Han; Hana Muellerova; Douglas Curran-Everett; Mark T Dransfield; George R Washko; Elizabeth A Regan; Russell P Bowler; Terri H Beaty; John E Hokanson; David A Lynch; Paul W Jones; Antonio Anzueto; Fernando J Martinez; James D Crapo; Edwin K Silverman; Barry J Make Journal: Lancet Respir Med Date: 2012-09-03 Impact factor: 30.700
Authors: Richard H Stanford; Maggie Tabberer; Mark Kosinski; Phaedra T Johnson; John White; Maureen Carlyle; Nicole A Tillery Journal: Chronic Obstr Pulm Dis Date: 2020-01
Authors: Kevin Gruffydd-Jones; Helen Marsden; Steve Holmes; Peter Kardos; Roger Escamilla; Roberto Dal Negro; June Roberts; Gilbert Nadeau; David Leather; Paul Jones Journal: BMC Med Res Methodol Date: 2013-05-10 Impact factor: 4.615